161 related articles for article (PubMed ID: 23520313)
1. Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation.
Scotton CJ; Hayes B; Alexander R; Datta A; Forty EJ; Mercer PF; Blanchard A; Chambers RC
Eur Respir J; 2013 Dec; 42(6):1633-45. PubMed ID: 23520313
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model.
Vande Velde G; De Langhe E; Poelmans J; Dresselaers T; Lories RJ; Himmelreich U
Invest Radiol; 2014 Nov; 49(11):691-8. PubMed ID: 24872004
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume.
Vande Velde G; Poelmans J; De Langhe E; Hillen A; Vanoirbeek J; Himmelreich U; Lories RJ
Dis Model Mech; 2016 Jan; 9(1):91-8. PubMed ID: 26563390
[TBL] [Abstract][Full Text] [Related]
4. A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice.
Ruscitti F; Ravanetti F; Donofrio G; Ridwan Y; van Heijningen P; Essers J; Villetti G; Cacchioli A; Vos W; Stellari FF
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29708527
[TBL] [Abstract][Full Text] [Related]
5. The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection.
Smoktunowicz N; Alexander RE; Franklin L; Williams AE; Holman B; Mercer PF; Jarai G; Scotton CJ; Chambers RC
Dis Model Mech; 2015 Sep; 8(9):1129-39. PubMed ID: 26138704
[TBL] [Abstract][Full Text] [Related]
6. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.
Peng R; Sridhar S; Tyagi G; Phillips JE; Garrido R; Harris P; Burns L; Renteria L; Woods J; Chen L; Allard J; Ravindran P; Bitter H; Liang Z; Hogaboam CM; Kitson C; Budd DC; Fine JS; Bauer CM; Stevenson CS
PLoS One; 2013; 8(4):e59348. PubMed ID: 23565148
[TBL] [Abstract][Full Text] [Related]
7. A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery.
Grandi A; Ferrini E; Zoboli M; Buseghin D; Pennati F; Khalajzeyqami Z; Ciccimarra R; Villetti G; Stellari FF
Am J Physiol Lung Cell Mol Physiol; 2024 Jun; 326(6):L736-L753. PubMed ID: 38651940
[TBL] [Abstract][Full Text] [Related]
8. Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography.
De Langhe E; Vande Velde G; Hostens J; Himmelreich U; Nemery B; Luyten FP; Vanoirbeek J; Lories RJ
PLoS One; 2012; 7(8):e43123. PubMed ID: 22912805
[TBL] [Abstract][Full Text] [Related]
9. Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters.
Wang Q; Wang Y; Hyde DM; Gotwals PJ; Koteliansky VE; Ryan ST; Giri SN
Thorax; 1999 Sep; 54(9):805-12. PubMed ID: 10456973
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis.
Gilhodes JC; Julé Y; Kreuz S; Stierstorfer B; Stiller D; Wollin L
PLoS One; 2017; 12(1):e0170561. PubMed ID: 28107543
[TBL] [Abstract][Full Text] [Related]
11. Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.
Vittal R; Fisher A; Gu H; Mickler EA; Panitch A; Lander C; Cummings OW; Sandusky GE; Wilkes DS
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):47-57. PubMed ID: 23470623
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of rosiglitazone on bleomycin-induced lung fibrosis: Assessed by micro-computed tomography and pathologic scores.
Jin GY; Bok SM; Han YM; Chung MJ; Yoon KH; Kim SR; Lee YC
Eur J Radiol; 2012 Aug; 81(8):1901-6. PubMed ID: 21296518
[TBL] [Abstract][Full Text] [Related]
13. In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach.
Mecozzi L; Mambrini M; Ruscitti F; Ferrini E; Ciccimarra R; Ravanetti F; Sverzellati N; Silva M; Ruffini L; Belenkov S; Civelli M; Villetti G; Stellari FF
Sci Rep; 2020 Oct; 10(1):18735. PubMed ID: 33127949
[TBL] [Abstract][Full Text] [Related]
14. Serial micro-CT assessment of the therapeutic effects of rosiglitazone in a bleomycin-induced lung fibrosis mouse model.
Choi EJ; Jin GY; Bok SM; Han YM; Lee YS; Jung MJ; Kwon KS
Korean J Radiol; 2014; 15(4):448-55. PubMed ID: 25053904
[TBL] [Abstract][Full Text] [Related]
15. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
[TBL] [Abstract][Full Text] [Related]
16. Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
Lin C; Duitman J; Daalhuisen J; Ten Brink M; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
Thorax; 2014 Feb; 69(2):152-60. PubMed ID: 24029744
[TBL] [Abstract][Full Text] [Related]
17. TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment.
Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; Boomershine CS; Ortiz C; Sherrill TP; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
Am J Physiol Lung Cell Mol Physiol; 2011 Jun; 300(6):L887-97. PubMed ID: 21441353
[TBL] [Abstract][Full Text] [Related]
18. Intracellular hydroxyproline imprinting following resolution of bleomycin-induced pulmonary fibrosis.
Song S; Fu Z; Guan R; Zhao J; Yang P; Li Y; Yin H; Lai Y; Gong G; Zhao S; Yu J; Peng X; He Y; Luo Y; Zhong N; Su J
Eur Respir J; 2022 May; 59(5):. PubMed ID: 34561295
[TBL] [Abstract][Full Text] [Related]
19. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
[TBL] [Abstract][Full Text] [Related]
20. PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
Bondue B; Sherer F; Van Simaeys G; Doumont G; Egrise D; Yakoub Y; Huaux F; Parmentier M; Rorive S; Sauvage S; Lacroix S; Vosters O; De Vuyst P; Goldman S
J Nucl Med; 2015 Jan; 56(1):127-32. PubMed ID: 25537989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]